Objective: Pharmacoresistance is a problem affecting ∼30% of chronic epilepsy
| INTRODUCTION
In chronic epilepsy, there is an urgent need for novel antiepileptic drugs (AEDs). Currently, seizures in ∼30% of epilepsy patients are insufficiently controlled by drug therapy; this number can be much higher in subtypes of focal epilepsy. An understanding of the mechanisms of pharmacoresistance is therefore mandatory and requires a precise understanding of how AEDs interact with their targets in control and epileptic tissue.
We had previously shown that transient Na + channels in chronically epileptic tissue exhibit a key change that renders them less susceptible to the anticonvulsant drug carbamazepine (CBZ); use-dependent block of transient Na + channels is lost in both human and experimental epilepsy, suggesting that this is a key mechanism underlying pharmacoresistance to CBZ on the cellular level. 1, 2 We have shown that eslicarbazepine (also [S]-licarbazepine [S-Lic]) overcomes this potential cellular resistance mechanism to conventional AEDs. 3 S-Lic is the active metabolite of eslicarbazepine acetate, a third-generation member of the dibenzazepine family of AEDs. After oral administration, eslicarbazepine acetate is hydrolyzed to S-Lic, which constitutes its major active metabolite. 4 These studies, however, have examined only fast activation, inactivation, and recovery from inactivation. These processes take place on a millisecond time scale, as is appropriate for mediating rapid events such as action potentials. However, sodium channels invariably show slow inactivation processes that can modulate the availability of Na + channels on a time scale of seconds to minutes. Slow inactivation processes can powerfully modulate the availability of Na + channels in a membrane potential-dependent manner. In particular, slow inactivation and recovery will be invoked strongly during prolonged depolarization shifts or high-frequency activity. Thus, agents that modulate slow inactivation might potently interfere with ictogenesis under conditions of increased excitability. We have therefore systematically investigated effects of S-Lic on slow inactivation of sodium channels. We have examined sodium channels in isolated dentate granule cells (DGCs) and sensorimotor cortex pyramidal neurons of control versus chronically epileptic rats (pilocarpine model of epilepsy) as well as in DGCs isolated from surgical specimens obtained during epilepsy surgery.
| MATERIALS AND METHODS

| Pilocarpine animal model of epilepsy
Epileptic rats were generated as described previously. 3, 5 Briefly, male Wistar rats (∼200 g) obtained from Charles River (Wilmington, MA, USA) were housed under a 12-hour light/dark cycle and received food and water ad libitum. Status epilepticus (SE) was induced by single intraperitoneal injections of the muscarinic agonist pilocarpine (340 mg/kg; Sigma, Saint Louis, MO, USA) 30 minutes after the administration of methyl-scopolamine via the same route (1 mg/kg, Sigma), which aimed at reducing peripheral muscarinic effects. Around 50% (range = 20%-80%) of rats developed and survived SE. SE was attenuated and eventually terminated by a subcutaneous injection of diazepam (20 mg/kg; Ratiopharm, Ulm, Germany). Sedated animals were allowed to recover in individual cages and were video monitored for the development of chronic seizures starting approximately 2 weeks after SE. More than 75% (range = 50%-100%) of rats experienced video-documented and therefore behaviorally detectable seizures and were used as epileptic animals during this study. Animals that did not develop seizures following SE were not used in this study. Shaminjected control animals were treated equally but were injected with saline instead of pilocarpine. All experimental procedures were conducted in accordance with the guidelines of appropriate animal care committees.
| Surgical specimens from temporal lobe epilepsy patients
Hippocampal tissue was obtained from 11 pharmacoresistant epilepsy patients (average age = 42.09 ± 3.37 years) who underwent surgery to achieve improved seizure control (for details, see Table S1 ). Hippocampus sclerosis was reported in nine of 11 patients. Three of these patients
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• S-Lic has multiple modes of action, including fast inactivation and slow inactivation as well as antiepileptogenic activity suffered from additional pathologic features (ganglioglioma and malformations of cortical development), and in the last two patients less pronounced pathological correlates were apparent. Informed consent was obtained for use of the specimens. Studies on human tissue were approved by the institutional research ethics committee.
| Animal preparation-hippocampal slices
Experiments were performed 54.9 ± 2.4 days (control group) to 61.6 ± 6.9 days post-SE (pilocarpine group). Animals were anesthetized with ketamine (100 mg/kg) and xylazine (15 mg/kg) and subsequently perfused through the heart with ice-cold, carbogenated (95% O 2 , 5% CO 2 ; Linde, Munich, Germany) sucrose-based artificial cerebrospinal fluid (ACSF) comprising (in mmol/L) NaCl 60, sucrose 100, NaHCO 3 26, KCl 2.5, NaH 2 PO 4 1.25, MgCl 2 5, CaCl 2 1, and glucose 20, pH = 7.4, osmolality = 305 mOsm. The brain was rapidly removed and prepared for slicing.
| Preparation of rat and human hippocampal slices and dissociated dentate granule neurons
Horizontal hippocampal slices (rat, 300 μm; human, 400 μm) were prepared with a vibrating microslicer (VT1200S; Leica, Wetzlar, Germany) in carbogenated sucrose ACSF. Rat brains were sectioned in the same sucrose-based ACSF as was used during perfusion and subsequently transferred to a storage chamber filled with sucrose-based ACSF, prewarmed to 35°C in a water bath, where they remained for ∼20 minutes. adjusted with NaOH, osmolality = 315 mOsm, which also contained pronase (protease type XIV, 2 mg/mL, Sigma), saturated with oxygen (Linde) and warmed to 36°C. This step was followed by an equilibration period of 10 minutes at room temperature (21-24°C) and a washing step in enzyme-free trituration solution. The dentate gyrus was dissected, and the neurons were isolated with fire-polished Pasteur pipettes of decreasing aperture in a Nunc dish (3.5 cm; Thermo Scientific, Waltham, MA, USA). Cells were allowed to settle for 10 minutes before patch clamp experiments commenced.
| Animal preparation-sensorimotor cortex
Animals were sacrificed 34.2 ± 2.4 days (pilocarpine group) to 39.9 ± 4.4 days post-SE (control group). Following ketamine/xylazine anesthesia, rats were perfused through the heart with ice-cold and carbogenated ACSF comprising (in mmol/L) NaCl 130, NaHCO 3 26, KCl 3, NaH 2 PO 4 1.25, MgCl 2 2, CaCl 2 2, and glucose 10, pH = 7.4. The frontal portion of the brain was rapidly removed and prepared for slicing.
| Preparation of sensorimotor cortex slices and dissociated pyramidal neurons
On a vibrating microslicer, a single 500-μm-thick coronal slice comprising primary sensory and motor cortices was cut approximately 1.8 mm anterior to the bregma. Slicing in the same ice-cold carbogenated ACSF that was also used during perfusion was followed by a 1-hour recovery period in the same solution warmed to 32°C. Subsequently, half of a slice was incubated at 28°C for 90 minutes in oxygenated bicarbonate-free ACSF that contained 25 mmol/L HEPES instead and was freshly supplemented with 0.01 mmol/L cysteine and 19 U/mL papain on every experimental day. After a washing step in enzyme-free solution, 1-to 2-mm-wide gray matter chunks were prepared and either stored in enzyme-free solution or triturated in a Ca 2+ -free solution that contained 10 mmol/L ethyleneglycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid instead, as well as 2 mmol/L freshly added kynurenic acid as described previously. . C, On average, I NaT was reduced by 7.09 ± 3.26%, 3.40 ± 1.32%, and 2.27 ± 2.75% in response to 30 μmol/L S-Lic, further reduced by 19.72 ± 1.75%, 22.44 ± 2.22%, and 19.87 ± 7.97% following perfusion of 100 μmol/L S-Lic, and even further reduced by 24.05 ± 2.79%, 23.71 ± 2.49%, and 25.37 ± 3.75% in the presence of 300 μmol/L S-Lic, in granule cells isolated from sham-injected rats, epileptic rats, and human epilepsy patients, respectively. SE, status epilepticus osmolality = 310 mOsm adjusted with glucose. The recording pipettes were pulled from borosilicate glass capillaries (0.86 mm inner diameter, 1.5 mm outer diameter, with filament; Science Products, Hofheim, Germany) using a micropipette puller (Model P-97; Sutter Instruments, Novato, CA, USA) and were filled with intracellular solution that contained (in mmol/L) CsF 110, HEPES-Na 10, ethyleneglycoltetraacetic acid 11, MgCl 2 2, tetraethylammonium-Cl 20, Na 2 -GTP 0.5, ATP-Na 2 5, pH = 7.25 adjusted with CsOH, osmolality = 300 mOsmol. Patch pipettes displayed open tip resistances ranging from 4 to 7 MΩ in the bath solution. With the Nunc dish mounted on an inverted microscope (Axiovert 100; Zeiss, Gottingen, Germany), isolated granule cells were identified by their morphology as described previously. 7, 8 Putative cortical pyramidal neurons were selected by their roundish-triangular morphology independent of soma size, which could vary from slightly larger to several-fold the size of DGCs. After formation of tight seal-resistances > 1 GΩ, the plasma membranes were ruptured, and transient Na + currents (I NaT s), were recorded at room temperature under constant superfusion with oxygenated recording solution using a patch clamp amplifier (Axopatch 200B; Molecular Devices, Sunnyvale, CA, USA). Currents were filtered at 10 kHz, sampled at 50 kHz using a Digidata 1440A, and stored on a personal computer running Clampex 10.2 (Molecular Devices). Series resistance of recorded rat pyramidal neurons, and rat and human granule cells was 7.18 ± 0.53 MΩ, 7.95 ± 0.21 MΩ, and 6.89 ± 0.38 MΩ, respectively, and could be compensated between 75% and 85% resulting in maximal residual voltage errors of 3.41 ± 0.39 mV and 4.48 ± 0.19 mV for rat and 3.94 ± 0.52 mV for human recordings. Leak current was generally below 300 pA, input resistance between 300 and 800 MΩ, and series resistance ranged from 5 to 10 MΩ. Cells deviating significantly from these values were discarded. Neurons experiencing jumps in leak current resulting in sudden alterations of the peak amplitude and neurons with a rapid rundown of current amplitude resulting in currents too small for meaningful analyses were also discarded.
Measured as well as command potentials were corrected for a calculated liquid junction potential of 10.0 mV. 13 .75, pH = 7.4 adjusted with HCl. Patch pipettes were pulled from borosilicate glass capillaries (0.86 mm inner diameter, 1.5 mm outer diameter, with filament; Warner Instruments, Hamden, CT, USA) on a vertical micropipette puller (P-10; Narishige, Tokyo, Japan) and filled with intracellular solution of identical composition as used for isolated cells. Open tip resistances ranged between 2 and 7 MΩ, series resistance was 7.52 ± 0.30 MΩ, and resistance was compensated by at least 50%. Recordings were obtained using an EPC-9/10 patch clamp amplifier (HEKA, Lambrecht, Germany) and PatchMaster software (HEKA) under the same conditions as stated above for isolated neurons.
| Expression systems
F I G U R E 2
Increased entry into slow inactivation. A, Entry of Na + channels into slow inactivation was induced by depolarizing dentate granule cells (DGCs) with a conditioning pulse for 1, 10, or 30 seconds from −90 mV holding potential to −10 mV. To allow recovery from fast inactivation, cells were repolarized for 1 second, and subsequently the fraction of channels available was determined by a 15-millisecond test pulse. The reduction compared to the current amplitude initiated by the conditioning pulse is due to slow inactivation. B, Representative recordings of Na + currents elicited by different conditioning pulses (black traces) or the test pulse 1 second after the end of the depolarizations (red traces). Examples from a granule cell of a sham-injected rat, a pilocarpine-treated rat, and an epilepsy patient. C, Lower transient Na+ current amplitudes as seen in B indicate increased slow inactivation of Na + channels in response to longer conditioning pulse durations. In both sham-injected and pilocarpine-treated rats, blocking effects increased slightly after washin of 300 μmol/L (S)-licarbazepine (S-Lic). D, Additional blocking effects were also seen in human DGCs. E, All three experimental groups do not differ in observed S-Lic effect sizes at any conditioning pulse duration. *P < 0.05, **P < 0.01, and ***P < 0.001. ACSF, artificial cerebrospinal fluid; SE, status epilepticus
| Drugs
Stock solutions of S-Lic (obtained from Bial, São Mamede do Coronado, Portugal) were prepared freshly once per experimental day in dimethylsulfoxide (Merck, Darmstadt, Germany; Sigma) and added to the recording solution at 1:1000 (isolated cells). For cultured cells, the stock solution was diluted in recording solution and the final dimethylsulfoxide concentration was adjusted to 0.4% in all groups. The drug-free recording solution always contained equal amounts of dimethylsulfoxide. Throughout the Results and Discussion, the drug-free recording solution will be abbreviated as "base & wash" or "ACSF," although being of different composition than ACSF stated above, whereas an identical solution containing S-Lic will be termed "S-Lic" with or without the respective concentration. In expression systems, only one test concentration or ACSF was tested per cell.
| Data analysis-isolated neurons
For the drug-dependent reduction of the peak I NaT amplitude, currents recorded in drug-free recording solution (average of the first current of the washin phase and the last current of the washout phase of S-Lic) were compared to currents recorded in bath solution containing additional S-Lic (average of the last current of the drug washin and the current recorded at the beginning of the washout phase). The change in I NaT amplitudes was analyzed by comparing normalized currents elicited (by test pulses) during inactivation to the initial current amplitude (elicited by the conditioning pulse or a test pulse preceding the conditioning pulse) of each recording. Also, baseline values before washin of S-Lic and values after washout of the drug were averaged and compared to the values of the S-Lic recordings to correct for rundown effects over the duration of the experiments. Datasets for the voltage dependence of slow inactivation were additionally normalized to the current recorded after hyperpolarizing the granule cell, as this was generally the largest of all recorded currents.
The time course of the recovery of slow inactivation was fitted to the following biexponential function using a Levenberg-Marquardt algorithm:
with τ slow1 and τ slow2 being the slow and ultraslow time constant of recovery, A slow1 and A slow2 as their relative amplitude contributions, and I(t) as the normalized current amplitude at time point t offset by A 0 .
| Data analysis-cultured cells
In cultured cells, only one test concentration was tested per cell. The ratio of normalized (I norm ) amplitudes obtained after and before the conditioning pulse was plotted against the conditioning pulse voltage for each tested concentration and fitted with a sigmoidal equation:
ððV 50 ÀXÞÃHÞ with I max being the maximal normalized current fixed to 1 and I min the remaining fraction of not slowly inactivated channels, X being the command potential, V 50 the potential at half maximal inactivation, and H the Hill coefficient. Table S3 . Fitting and statistics were made in Prism 7 (GraphPad Software, La Jolla, CA, USA).
| Statistical analysis
| RESULTS
| S-Lic reduces I NaT amplitudes at resting membrane potential
We first determined the effects of S-Lic on sodium currents elicited from (hyperpolarized) potentials close to the resting membrane potential of DGCs, at which channels are fully recovered from fast inactivation. I NaT was evoked by depolarizing DGCs from −90 mV to −10 mV before, during, and after perfusion of different concentrations (30, 100, 300 μmol/L) of S-Lic ( Figure 1A ). Concentration-dependent effects of S-Lic on I NaT could be observed in granule cells isolated from sham-injected rats, epileptic rats, and human epilepsy patients ( Figure 1B , black vs blue traces, summary with numbers given in Figure 1C) . These data suggest that S-Lic exerts strong effects on sodium channels aside from the known effects on fast inactivation.
| S-Lic effects on entry into and recovery from slow inactivation
We next tested the idea that the entry into slow inactivation, or the recovery from slow inactivated states, is affected by S-Lic. Entry of Na + channels into slow inactivation was induced by depolarizing rat and human DGCs for 1, 10, or 30 seconds from −90 mV holding potential to −10 mV. A 15-millisecond test pulse 1 second after the end of the conditioning pulse was used to determine the reduction of the I NaT amplitude by slow inactivation processes, as described previously (Figure 2A ). In DGCs of sham-injected and epileptic rats as well as human patients, increasing the duration of the conditioning prepulses from 1 to 30 seconds caused a strong reduction in I NaT due to increased entry into slow inactivation (Figure 2B , red traces vs black traces). In both rat groups, the fraction of channels entering slow inactivation was 
F I G U R E 3
Unaltered recovery from slow inactivation. A, The time course of recovery from Na + channel slow inactivation was studied by applying 50 additional test pulses every 3 seconds following the conditioning pulse used to induce slow inactivation. B, Individual currents recorded in response to the conditioning pulse and test pulses to track recovery from slow inactivation over time for dentate granule cells (DGCs) isolated from normal rats, epileptic rats, and human epilepsy patients. C, Average recovery time course for both groups of rat granule cells in drug-free recording solution and under 300 μmol/L (S)-licarbazepine (S-Lic). D, Equivalent experimental results for human DGCs. ACSF, artificial cerebrospinal fluid; SE, status epilepticus enhanced in response to 300 μmol/L S-Lic ( Figure 2C , two-way ANOVA, sham control: F 1, 18 = 38.69, P < 0.001; post-SE: F 1, 18 = 52.82, P < 0.001, with *P < 0.05, **P < 0.01, and ***P < 0.001 in Bonferroni multiple comparisons test for S-Lic efficacy). Similar results were obtained from human epileptic DGCs (Figure 2D , two-way ANOVA, human epilepsy:
with Dunn multiple comparisons test, not significant).
Lower concentrations of S-Lic (100 μmol/L, Figure S1 ) similarly increased the entry into slow inactivation (Figure S1B , C, and D, experiments done as in Figure 2) . Again, the effect sizes were indistinguishable between both rat groups ( Figure S1D , Mann-Whitney test, not significant). Collectively, these data show significant, but small, effects on entry into slow inactivation, with magnitudes below 10% of the maximal current amplitude. We then studied the time course of recovery from Na + channel slow inactivation using established protocols. Briefly, slow inactivation was induced with a prolonged voltage step of 1, 10, or 30 seconds. Subsequently, the recovery from inactivation was monitored using brief test pulses applied every 3 seconds ( Figure 3A ). This protocol allows determination of the time course of recovery as a gradual increase in the I NaT measured during the brief test pulses ( Figure 3B , examples depicted for sham-control rats, epileptic rats, and human epilepsy patients in the absence and presence of 300 μmol/L S-Lic). The average recovery time course for both groups of rat granule cells and for human granule cells is depicted in Figure 3C and 3D, respectively. Similar recordings with 100 μmol/L S-Lic are depicted in Figure S2 . As already apparent from these recordings and recovery time courses, the time constants derived after fitting the recovery of individual granule neurons were also largely unaffected by 100 or 300 μmol/L SLic ( Figure S3 , paired t test for comparison of recovery time constants, Wilcoxon matched-pairs test for comparison of fractions of slow and ultraslow recovery). Thus, both entry and recovery from inactivation are largely unaffected even by high concentrations of S-Lic (300 μmol/L).
| S-Lic strongly shifts the voltage dependence of slow inactivation to hyperpolarized potentials
To determine additional mechanisms that could account for the reduction in I NaT via effects on slow inactivation, we studied whether S-Lic affects the voltage dependence of slow inactivation. To this end, we used a conditioning voltage protocol consisting of 10-second steps to various voltages between −110 mV and −30 mV to induce slow inactivation. Voltage-dependent inactivation was then assessed by determining the fraction of I NaT inactivated by the conditioning pulse ( Figure 4A , I NaT assessed by brief test pulses before and after the conditioning pulse). Representative recordings are shown in Figure 4B for I NaT preceding a conditioning pulse (black lines) and I NaT evoked after the conditioning pulse (10 seconds, −70 mV, red lines).
In the presence of 100 μmol/L S-Lic, significant reductions in I NaT amplitudes were found for all conditioning pulse voltages in rat as well as human granule cells (Figure 4C , two-way ANOVA, sham control: F 1, 52 = 189.1, P < 0.001; pilocarpine-treated: F 1, 48 = 301.2, P < 0.001; human epilepsy: F 1, 24 = 73.24, P < 0.001; followed by Bonferroni multiple comparisons test for S-Lic efficacy with **P < 0.01 and ***P < 0.001). We performed equivalent experiments applying 30 μmol/L and 300 μmol/L S-Lic (summarized in Figure 4E ). Whereas 30 μmol/L S-Lic resulted in nonsignificant shifts, the effects seen for 300 μmol/L S-Lic were slightly more prominent than those observed for 100 μmol/L S-Lic. (Figure 4D , two-way ANOVA, sham control: F 1, 20 = 162.7, P < 0.001; pilocarpine-treated: F 1, 20 = 71.43, P < 0.001; human epilepsy: F 1, 16 = 229.5, P < 0.001; followed by Bonferroni multiple comparisons test for S-Lic efficacy with *P < 0.05, **P < 0.01, and ***P < 0.001). For all tested drug concentrations, the efficacy of S-Lic on DGCs was unaltered between nonepileptic and epileptic rats ( Figure 4E , white and black bars, Mann-Whitney test, not significant) as well as between rats and human epilepsy patients (Kruskal-Wallis test with Dunn multiple comparisons test, not significant). These data indicate that strong effects of S-Lic are observed on the voltage dependence of slow inactivation that seem to saturate at concentrations > 100 μmol/L.
F I G U R E 4
Potent hyperpolarizing shifts of the voltage dependence of slow inactivation. A, Voltage step protocol used to study the voltage dependence of Na + channel slow inactivation. A short test pulse to −10 mV was followed by variable conditioning pulse potentials ranging from −110 to −30 mV. Another test pulse was applied after recovery from fast inactivation at holding potential (−90 mV) 1 second after the end of the conditioning pulse. B, Representative examples of recorded Na + currents elicited by the test pulse before (black lines) and after a 10-second conditioning pulse to −70 mV (red lines). Note overall reduced current amplitudes and increased slow inactivation in the presence of 100 μmol/L (S)-licarbazepine (S-Lic). C, D, Summary of individual test pulse amplitudes normalized to the averaged baseline and washout test pulse amplitude following the −110-mV conditioning pulse. Averaged baseline and washout amplitudes (white symbols) were compared to those recorded under S-Lic (black symbols; C, 100 μmol/L; D, 300 μmol/L), resulting in significant amplitude reductions caused by a prominent hyperpolarizing shift of the voltage dependence. E, Effects of 30, 100, and 300 μmol/L S-Lic on the voltage dependence of slow inactivation for all three experimental groups were compared for each conditioning pulse voltage. None of the tested S-Lic concentrations resulted in significant differences at any tested conditioning pulse voltage, irrespective of comparing only healthy and epileptic rats (white vs black bars, MannWhitney test, not significant) or both rat groups and human epilepsy patients (white, black, and gray bars, Kruskal-Wallis test with Dunn multiple comparisons test, not significant). *P < 0.05, **P < 0.01, and ***P < 0.001. SE, status epilepticus
They also demonstrate that these effects are maintained in chronic experimental and human epilepsy.
| S-Lic shows similar efficacy in epileptic and healthy cortical pyramidal neurons
We were curious whether the efficacy of S-Lic in chronic epileptic tissue is limited to hippocampal neurons or extends to extrahippocampal brain areas. Therefore, we studied the effects of S-Lic on voltage dependence of slow inactivation in isolated neocortical pyramidal neurons in nonepileptic and epileptic rats ( Figure 5A ). Similar to the results in DGCs, 100 μmol/L S-Lic reduced the maximal average I NaT amplitude by 16.2 ± 3.9% and 19.7 ± 4.4% in sham control and pilocarpine-treated rats, respectively (examples in Figure 5B , calculated as for DGCs in Bonferroni multiple comparisons test for S-Lic efficacy with *P < 0.05, **P < 0.01, and ***P < 0.001). D, No significant differences in effect sizes between epileptic and nonepileptic pyramidal neurons at any tested voltage Figure 1 ). Voltage-dependent S-Lic effects were also observed in pyramidal neurons, again with the strongest effects at intermediate voltages close to the resting membrane potential ( Figure 5C and 5D). The drug effect sizes were also indistinguishable between pyramidal neurons isolated from healthy and epileptic brains ( Figure 5D , Mann-Whitney test, not significant). From these data, we conclude that S-Lic exerts antiepileptic potency in DGCs as well as cortical pyramidal neurons to a similar extent, both in epileptic and nonepileptic tissue. 
sodium channel isoforms
Finally, we investigated the effects of different concentrations of S-Lic on relevant brain sodium channel isoforms expressed in either CHO or HEK cells. In these experiments, we were able to assess a more extensive range of voltage, due to the high stability of recordings in expression systems ( Figure 6A ). In cells expressing Na v 1.1 or Na v 1.3 channels, no or very limited effects on the voltage dependence of slow inactivation were observed up to concentrations of 1000 μmol/L S-Lic ( Figure 6B , left panels). In contrast, in cells expressing Na v 1.2 or Na v 1.6, a strong hyperpolarizing shift of the voltage-dependence curves and an additional increase in the fraction of slow inactivated channels could be observed in the presence of S-Lic ( Figure 6B , right panels). These effects were strongly dosedependent and increased with higher concentrations of S-Lic. Interestingly and in contrast to all other tested sodium channel isoforms, obvious yet insignificant S-Lic effects on Na v 1.2 channels were already apparent at very low S-Lic concentrations of 10 μmol/L (Table S2 ; ANOVA followed by Dunnett posttest for V 50 and Kruskal-Wallis test followed by Dunn posttest for I min ).
| DISCUSSION
The main result of this study is that S-Lic exhibits strong effects of sodium channel slow inactivation, mainly via effects on the voltage dependence of slow inactivation in native human and rat neurons. These effects are confined to Na v 1.2 and Na v 1.6 subunits and are not observed in Na v 1.1 and Na v 1.3 subunits. Moreover, the efficacy of S-Lic in modulating slow inactivation voltage dependence is maintained in chronic human and experimental epilepsy and extends to principal cells of at least the two investigated brain areas. The strong effects on slow inactivation seen for S-Lic have been observed previously in expression systems. 9 Similar effects are shared by some other AEDs. Lacosamide also exerts effects on slow inactivation in different types of neurons. 5, 10, 11 Moreover, as seen for S-Lic, lacosamide also shifts the voltage dependence of slow inactivation in a hyperpolarizing direction as a major effect, whereas other effects on slow inactivation were small. 5, 10 In contrast to those AEDs, the effects of CBZ on slow inactivation are virtually negligible, with well-known pronounced effects on fast inactivation processes. 9 Lacosamide does differ from S-Lic in that effects on fast inactivation voltage dependence were undetectable or small, 5, 10, 11 whereas S-Lic does have significant effects on fast sodium channel gating in native neurons. 3 Another study, however, did not find significant S-Lic effects on fast inactivation in expression systems. 9 These findings underscore that sodium channel blockers are not by any means equivalent. Rather, they show marked differences in how they act on different kinetic parameters of sodium channels, in this case in particular slow versus fast inactivation. The structural basis for these differences is unclear, but the question of why these compounds behave differently is intriguing. Molecular modeling approaches may be extremely useful to determine candidate mechanisms related to the interaction between AEDs and channel structures.
12
A further difference between AEDs is additional targets aside from voltage-gated Na + channels. Sodium channels are not the only targets for S-Lic, with T-type calcium channels being another relevant target that may be responsible for antiepileptogenic mechanisms of action. 3 In contrast, sodium channels seem to be the major target for lacosamide, as binding studies have excluded binding of lacosamide to different types of γ-aminobutyric acid and glutamate receptors, as well as a variety of other neurotransmitter receptors, and voltage-gated potassium or calcium channels. 13, 14 A first question addressed in this study was whether the effects of S-Lic are maintained in chronic epilepsy. A previous study has shown that the active metabolite of the anticonvulsant eslicarbazepine acetate has potent usedependent effects in experimental and human epilepsy, and has add-on effects to CBZ. 3 Is this also the case for slow inactivation? Our data show that the answer to this question is yes. We observed quantitatively maintained effects of S-Lic not only on slow inactivation in experimental epilepsy, but also on sodium channels in granule cells obtained from epilepsy surgical specimens. This is similar to the maintained activity of lacosamide on slow inactivation and use-dependent block in chronic experimental and human epilepsy that was observed in a previous study. 5 In addition, we have shown that the maintained activity also extends to cortical areas, which also display pathological changes in chronic epilepsy models. [15] [16] [17] Given the prominent effects of S-Lic on the voltage dependence of slow inactivation in different types of native neurons, we examined which Na channel alpha subunits are responsible for this effect. The results were surprisingly clear-Na v 1.1 and Na v 1.3 slow inactivation is not affected by S-Lic even at high concentrations, whereas strong effects are seen for Na v 1.2 and Na v 1.6. The largest effects of S-Lic could be observed on Na v 1.2 channels with potent effects even at low concentrations of 10 μmol/L. Na v 1.2 and Na v 1.6 channels are both expressed prominently in principal neurons. In contrast, Na v 1.1 is strongly expressed in fast-spiking interneurons. 18 This may argue for a cell type-specific inhibitory action of S-Lic that spares interneurons enriched in Na v 1.1. Moreover, this specificity positions S-Lic as a potential anticonvulsant therapy in diseases with compromised Na v 1.1 function in interneurons, such as loss-of-function Na v 1.1 mutations or Alzheimer's disease. [19] [20] [21] [22] Intriguingly, in Alzheimer's disease, anticonvulsants that block Na + channels indiscriminately are ineffective, presumably because they further impair interneuron functionality, whereas levetiracetam, which has a presynaptic mode of action, is effective. 23 This and these previous studies suggest that AED effects on slow inactivation are an important mode of action that is surprisingly isoform specific. Two important considerations emerge from these and published data. First, it may be important to develop AEDs with multiple modes of action such as S-Lic; however, far from being indiscriminate, each of these modes of action shows a sometimes surprising specificity for ion channel isoforms. It has been argued with a similar logic that classical use-dependent Na + channel blockers could be meaningfully combined with other compounds with different specificity. Future studies will have to show whether combining specific modes of action shows synergistic effects, both in animal models and in humans. Second, it will be increasingly important to show that anticonvulsant mechanisms of action are maintained in chronic epilepsy, as shown for S-Lic with respect to effects on both fast and slow inactivation. Developing such compounds with multiple specific mechanisms of action that are stable even in chronic epilepsy will be important to overcome target mechanisms of pharmacoresistance.
